A New Player in the Weight Loss Game
In a world where convenience often dictates our choices, the FDA’s approval of Foundayo, a once-daily GLP-1 pill, is a significant development in weight management. The pill, manufactured by Eli Lilly, offers a new option for those struggling with obesity or weight-related conditions. Unlike its injectable counterparts, Foundayo can be taken with or without food, making it a more accessible choice for many.
The approval comes as part of the FDA’s National Priority Voucher pilot program, which aims to expedite the availability of medications addressing national health priorities. Foundayo’s journey to approval was swift, with the FDA greenlighting it just 50 days after submission. This rapid approval underscores the urgency of addressing obesity, a growing concern in many parts of the world.
The Science Behind Foundayo
Foundayo is an oral GLP-1 receptor agonist designed to aid weight loss when combined with a reduced-calorie diet and increased physical activity. The medication’s efficacy was demonstrated in two randomized, double-blind, placebo-controlled trials. Participants on the highest dose of Foundayo lost an average of 27 pounds, a stark contrast to the 2 pounds shed by those on a placebo.
However, like many medications, Foundayo is not without its side effects. Users may experience nausea, constipation, diarrhea, and other gastrointestinal issues. The drug also carries a warning about potential thyroid C-cell tumors, a risk that patients must weigh against the benefits of weight loss.
The Convenience Factor
One of the standout features of Foundayo is its convenience. Unlike the Wegovy pill, which requires an empty stomach and a waiting period before eating, Foundayo can be taken at any time, with or without food. This flexibility makes it an attractive option for those who find the regimen of injections or fasting before medication cumbersome.
David Ricks, CEO of Eli Lilly, emphasized the real-world applicability of Foundayo, stating that it levels the playing field for those living with obesity. As a once-daily pill, it offers a practical solution for individuals who prefer not to deal with the logistics of injectable medications.
Beyond Medication: Lifestyle Adjustments
While Foundayo offers a promising option for weight management, experts stress that medication should be part of a broader lifestyle change. Dr. Pouya Shafipour and other health professionals advocate for a diet high in protein and fiber, coupled with regular aerobic and strength-building exercises. These habits not only aid weight loss but also improve overall health.
In addition to dietary changes, managing stress, getting adequate sleep, and reducing alcohol intake are crucial components of a successful weight management strategy. The CDC recommends at least 150 minutes of moderate-intensity exercise per week, alongside strength training, to maintain a healthy lifestyle.
Facts Worth Knowing
- •💡 Foundayo was approved 50 days after submission under the FDA’s National Priority Voucher pilot program.
- •💡 Participants in the ATTAIN-1 trial lost an average of 27 pounds on the highest dose of Foundayo.
- •💡 Foundayo can be taken with or without food, unlike some other GLP-1 medications.
